{"id":"https://openalex.org/W2331511244","doi":"https://doi.org/10.1097/00000421-199610000-00012","title":"A Phase II Trial of VP-16, Ifosfamide, Cisplatin, Vinblastine, and Bleomycin in Advanced Germ-Cell Tumors","display_name":"A Phase II Trial of VP-16, Ifosfamide, Cisplatin, Vinblastine, and Bleomycin in Advanced Germ-Cell Tumors","publication_year":1996,"publication_date":"1996-10-01","ids":{"openalex":"https://openalex.org/W2331511244","doi":"https://doi.org/10.1097/00000421-199610000-00012","mag":"2331511244","pmid":"https://pubmed.ncbi.nlm.nih.gov/8823477"},"language":"en","primary_location":{"id":"doi:10.1097/00000421-199610000-00012","doi":"https://doi.org/10.1097/00000421-199610000-00012","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00000421-199610000-00012","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5037149615","display_name":"Charles David Blanke","orcid":"https://orcid.org/0000-0002-6493-7834","observed_orcids":["https://orcid.org/0000-0002-6493-7834"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]},{"id":"https://openalex.org/I592451","display_name":"Indiana University","ror":"https://ror.org/01kg8sb98","country_code":"US","type":"education","lineage":["https://openalex.org/I592451"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Charles Blanke","raw_affiliation_strings":["Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA","Division of Hematology-Oncology, Department of Medicine (P.J.L., C.R.N., L.H.E.), Indiana University Medical Center, Indianapolis, Indiana","From the Division of Medical Oncology, Department of Medicine (C.B.), Vanderbilt University Medical Center, Nashville, Tennessee","Supported in part by National Cancer Institute grant 2 R 35 CA 39844-09, General Clinical Research Center grant MO 1 RR 00 750-06, a grant from Amgen, Inc., and the Walther Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee 37232, USA","institution_ids":["https://openalex.org/I901861585"]},{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Medicine (P.J.L., C.R.N., L.H.E.), Indiana University Medical Center, Indianapolis, Indiana","institution_ids":["https://openalex.org/I4394709130","https://openalex.org/I592451"]},{"raw_affiliation_string":"From the Division of Medical Oncology, Department of Medicine (C.B.), Vanderbilt University Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I901861585"]},{"raw_affiliation_string":"Supported in part by National Cancer Institute grant 2 R 35 CA 39844-09, General Clinical Research Center grant MO 1 RR 00 750-06, a grant from Amgen, Inc., and the Walther Cancer Institute","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5021904320","display_name":"Patrick Joseph Loehrer","orcid":"https://orcid.org/0000-0002-1532-4660","observed_orcids":["https://orcid.org/0000-0002-1532-4660"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]},{"id":"https://openalex.org/I592451","display_name":"Indiana University","ror":"https://ror.org/01kg8sb98","country_code":"US","type":"education","lineage":["https://openalex.org/I592451"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Patrick J. Loehrer","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Medicine (P.J.L., C.R.N., L.H.E.), Indiana University Medical Center, Indianapolis, Indiana","From the Division of Medical Oncology, Department of Medicine (C.B.), Vanderbilt University Medical Center, Nashville, Tennessee","Supported in part by National Cancer Institute grant 2 R 35 CA 39844-09, General Clinical Research Center grant MO 1 RR 00 750-06, a grant from Amgen, Inc., and the Walther Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Medicine (P.J.L., C.R.N., L.H.E.), Indiana University Medical Center, Indianapolis, Indiana","institution_ids":["https://openalex.org/I4394709130","https://openalex.org/I592451"]},{"raw_affiliation_string":"From the Division of Medical Oncology, Department of Medicine (C.B.), Vanderbilt University Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I901861585"]},{"raw_affiliation_string":"Supported in part by National Cancer Institute grant 2 R 35 CA 39844-09, General Clinical Research Center grant MO 1 RR 00 750-06, a grant from Amgen, Inc., and the Walther Cancer Institute","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048544130","display_name":"Craig R. Nichols","orcid":"https://orcid.org/0000-0002-6256-1511","observed_orcids":["https://orcid.org/0000-0002-6256-1511"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]},{"id":"https://openalex.org/I592451","display_name":"Indiana University","ror":"https://ror.org/01kg8sb98","country_code":"US","type":"education","lineage":["https://openalex.org/I592451"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Craig R. Nichols","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Medicine (P.J.L., C.R.N., L.H.E.), Indiana University Medical Center, Indianapolis, Indiana","From the Division of Medical Oncology, Department of Medicine (C.B.), Vanderbilt University Medical Center, Nashville, Tennessee","Supported in part by National Cancer Institute grant 2 R 35 CA 39844-09, General Clinical Research Center grant MO 1 RR 00 750-06, a grant from Amgen, Inc., and the Walther Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Medicine (P.J.L., C.R.N., L.H.E.), Indiana University Medical Center, Indianapolis, Indiana","institution_ids":["https://openalex.org/I4394709130","https://openalex.org/I592451"]},{"raw_affiliation_string":"From the Division of Medical Oncology, Department of Medicine (C.B.), Vanderbilt University Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I901861585"]},{"raw_affiliation_string":"Supported in part by National Cancer Institute grant 2 R 35 CA 39844-09, General Clinical Research Center grant MO 1 RR 00 750-06, a grant from Amgen, Inc., and the Walther Cancer Institute","institution_ids":["https://openalex.org/I4210140884"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5048660181","display_name":"Lawrence H. Einhorn","orcid":"https://orcid.org/0000-0001-7971-7669","observed_orcids":["https://orcid.org/0000-0001-7971-7669"]},"institutions":[{"id":"https://openalex.org/I4210140884","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210140884"]},{"id":"https://openalex.org/I4394709130","display_name":"Indiana University School of Medicine","ror":"https://ror.org/02ets8c94","country_code":"US","type":"education","lineage":["https://openalex.org/I4394709130","https://openalex.org/I592451"]},{"id":"https://openalex.org/I592451","display_name":"Indiana University","ror":"https://ror.org/01kg8sb98","country_code":"US","type":"education","lineage":["https://openalex.org/I592451"]},{"id":"https://openalex.org/I901861585","display_name":"Vanderbilt University Medical Center","ror":"https://ror.org/05dq2gs74","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210162197","https://openalex.org/I901861585"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Lawrence H. Einhorn","raw_affiliation_strings":["Division of Hematology-Oncology, Department of Medicine (P.J.L., C.R.N., L.H.E.), Indiana University Medical Center, Indianapolis, Indiana","From the Division of Medical Oncology, Department of Medicine (C.B.), Vanderbilt University Medical Center, Nashville, Tennessee","Supported in part by National Cancer Institute grant 2 R 35 CA 39844-09, General Clinical Research Center grant MO 1 RR 00 750-06, a grant from Amgen, Inc., and the Walther Cancer Institute"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Oncology, Department of Medicine (P.J.L., C.R.N., L.H.E.), Indiana University Medical Center, Indianapolis, Indiana","institution_ids":["https://openalex.org/I4394709130","https://openalex.org/I592451"]},{"raw_affiliation_string":"From the Division of Medical Oncology, Department of Medicine (C.B.), Vanderbilt University Medical Center, Nashville, Tennessee","institution_ids":["https://openalex.org/I901861585"]},{"raw_affiliation_string":"Supported in part by National Cancer Institute grant 2 R 35 CA 39844-09, General Clinical Research Center grant MO 1 RR 00 750-06, a grant from Amgen, Inc., and the Walther Cancer Institute","institution_ids":["https://openalex.org/I4210140884"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5037149615"],"corresponding_institution_ids":["https://openalex.org/I4210140884","https://openalex.org/I4394709130","https://openalex.org/I592451","https://openalex.org/I901861585"],"apc_list":null,"apc_paid":null,"fwci":1.6631,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.85363298,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"19","issue":"5","first_page":"487","last_page":"491"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11069","display_name":"Testicular diseases and treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11069","display_name":"Testicular diseases and treatments","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11141","display_name":"Childhood Cancer Survivors' Quality of Life","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/advanced-germ-cell-tumors","display_name":"advanced germ cell tumors","score":0.8809999823570251},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":0.9929999709129333},{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.996999979019165},{"id":"https://openalex.org/keywords/vinblastine","display_name":"vinblastine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/bleomycin","display_name":"bleomycin","score":1.0},{"id":"https://openalex.org/keywords/filgrastim","display_name":"filgrastim","score":0.7590000033378601},{"id":"https://openalex.org/keywords/complete-response-rate","display_name":"complete response rate","score":0.7009999752044678},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.9819999933242798},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.8230000138282776},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.9290000200271606},{"id":"https://openalex.org/keywords/bleomycin-pulmonary-toxicity","display_name":"bleomycin pulmonary toxicity","score":0.8220000267028809},{"id":"https://openalex.org/keywords/teratoma","display_name":"teratoma","score":0.7250000238418579},{"id":"https://openalex.org/keywords/chemotherapy-toxicity","display_name":"chemotherapy toxicity","score":0.40799999237060547}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8857927918434143},{"id":"https://openalex.org/C2777506904","wikidata":"https://www.wikidata.org/wiki/Q418560","display_name":"Ifosfamide","level":4,"score":0.854523777961731},{"id":"https://openalex.org/C2777132456","wikidata":"https://www.wikidata.org/wiki/Q282629","display_name":"Vinblastine","level":3,"score":0.7329989075660706},{"id":"https://openalex.org/C2780376820","wikidata":"https://www.wikidata.org/wiki/Q424997","display_name":"Mesna","level":5,"score":0.67905193567276},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.6580156683921814},{"id":"https://openalex.org/C2776232574","wikidata":"https://www.wikidata.org/wiki/Q415571","display_name":"Bleomycin","level":3,"score":0.6446374654769897},{"id":"https://openalex.org/C2776938808","wikidata":"https://www.wikidata.org/wiki/Q1737977","display_name":"Germ cell tumors","level":3,"score":0.6413190364837646},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5658357739448547},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5307809114456177},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5212419629096985},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.5159083604812622},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.45300427079200745},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.4236012399196625},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.3444518446922302}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D005047","descriptor_name":"Etoposide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007069","descriptor_name":"Ifosfamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007069","descriptor_name":"Ifosfamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014747","descriptor_name":"Vinblastine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D015996","descriptor_name":"Survival Rate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018237","descriptor_name":"Germinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018237","descriptor_name":"Germinoma","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D018237","descriptor_name":"Germinoma","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/00000421-199610000-00012","doi":"https://doi.org/10.1097/00000421-199610000-00012","is_oa":false,"landing_page_url":"https://doi.org/10.1097/00000421-199610000-00012","pdf_url":null,"source":{"id":"https://openalex.org/S130927242","display_name":"American Journal of Clinical Oncology","issn_l":"0277-3732","issn":["0277-3732","1537-453X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-2"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American Journal of Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:8823477","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8823477","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"American journal of clinical oncology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[{"id":"https://openalex.org/G1471804372","display_name":"CLINICAL TRIALS IN ONCOLOGY","funder_award_id":"5r35ca039844-10","funder_id":"https://openalex.org/F4320332161","funder_display_name":"National Institutes of Health"},{"id":"https://openalex.org/G3841049472","display_name":null,"funder_award_id":"2R 35 CA 39844-09","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"},{"id":"https://openalex.org/G579629039","display_name":null,"funder_award_id":"MO 1 RR 00750-06","funder_id":"https://openalex.org/F4320337375","funder_display_name":"National Center for Research Resources"}],"funders":[{"id":"https://openalex.org/F4320332161","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88"},{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"},{"id":"https://openalex.org/F4320337375","display_name":"National Center for Research Resources","ror":"https://ror.org/04pw6fb54"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1861752925","https://openalex.org/W1956443396","https://openalex.org/W1970781080","https://openalex.org/W1983482625","https://openalex.org/W2028988288","https://openalex.org/W2094521253","https://openalex.org/W2267740990","https://openalex.org/W2323139555"],"related_works":["https://openalex.org/W1925062343","https://openalex.org/W1793293593","https://openalex.org/W2473781792","https://openalex.org/W2156260710","https://openalex.org/W2070146394","https://openalex.org/W2317411149","https://openalex.org/W2077841943","https://openalex.org/W1868039889","https://openalex.org/W2151516332","https://openalex.org/W2416952867"],"abstract_inverted_index":{"PURPOSE:":[0],"A":[1],"Phase":[2],"II":[3],"study":[4],"to":[5,211],"evaluate":[6],"the":[7,54],"effect":[8],"of":[9,45,119,139,177,183,190],"a":[10,42,180,187,213],"five-drug":[11],"regimen,":[12],"VP-16,":[13],"ifosfamide,":[14],"cisplatin,":[15],"vinblastine,":[16],"and":[17,27,116,128,151,174,186],"bleomycin":[18,83,164],"(VIP/VB)":[19],"on":[20],"complete":[21,123,155],"response":[22],"rate,":[23],"continuous":[24],"disease-free":[25,135],"survival,":[26],"toxicity":[28,166,194,223],"in":[29,217],"patients":[30,40,109,147,170,200],"with":[31,41,51,125,136,179,198],"advanced":[32,218],"germ-cell":[33,47,220],"tumor.":[34],"PATIENTS":[35],"AND":[36],"METHODS:":[37],"Twenty":[38],"male":[39],"histologic":[43],"diagnosis":[44],"advanced-stage":[46],"cancer,":[48],"previously":[49],"untreated":[50],"chemotherapy,":[52],"received":[53],"following:":[55],"etoposide":[56],"75":[57],"mg/m2":[58,73],"i.v.":[59,68,74,80,86],"days":[60,69,75,92],"1-5;":[61,70,76],"ifosfamide":[62],"(with":[63],"mesna":[64],"uroprotection)":[65],"1.2":[66],"g/m2":[67],"cisplatin":[71],"20":[72,120,184],"vinblastine":[77],"0.18":[78],"mg/kg":[79],"day":[81,87],"1;":[82,88],"30":[84],"units":[85],"filgrastim":[89],"5":[90,131,152],"micrograms/kg":[91],"7-16.":[93],"Chemotherapy":[94],"was":[95,159,195,224],"given":[96],"every":[97],"3":[98,204],"weeks":[99],"(bleomycin":[100],"weekly":[101],"x":[102],"12)":[103],"for":[104,113],"four":[105],"courses.":[106],"RESULTS:":[107],"All":[108],"entered":[110],"were":[111,133],"evaluable":[112],"toxicity,":[114],"response,":[115],"survival.":[117],"Eleven":[118],"(55%)":[121],"achieved":[122],"remissions":[124],"chemotherapy":[126],"alone":[127],"an":[129],"additional":[130],"(25%)":[132],"rendered":[134],"surgical":[137],"resection":[138],"teratoma":[140],"(3)":[141],"or":[142,205],"viable":[143],"cancer":[144],"(2).":[145],"Two":[146],"relapsed":[148],"at":[149],"4":[150,206],"months":[153,185],"from":[154,163],"remission":[156],"(CR).":[157],"There":[158],"one":[160],"treatment-related":[161],"death,":[162],"lung":[165],"after":[167],"thoracotomy.":[168],"Thirteen":[169],"(65%)":[171],"are":[172],"alive":[173],"continuously":[175],"free":[176],"disease,":[178],"median":[181],"follow-up":[182,189],"minimal":[188],"12":[191],"months.":[192],"Hematologic":[193],"most":[196],"common,":[197],"16":[199],"(80%)":[201],"having":[202],"grade":[203],"leukopenia.":[207],"CONCLUSIONS:":[208],"VIP/VB":[209],"appears":[210],"be":[212],"very":[214],"active":[215],"regimen":[216],"disseminated":[219],"cancer.":[221],"Hematological":[222],"severe":[225],"but":[226],"manageable.":[227]},"counts_by_year":[{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}